What we do

Our vision

Is of a world where everyone with an Eosinophilic Gastrointestinal Disease can eat without pain.

Our mission

Is to ensure that every person with an Eosinophilic Gastrointestinal Disease receives a prompt accurate diagnosis, the right treatment for them, and support to live with their condition.

What we do

We provide information and support for people with Eosinophilic Gastrointestinal Diseases their families and carers, through our community hub, resources and events.
We provide a global platform for clinicians and researchers to connect and share the latest research and best evidence-based practice.
We provide educational resources and events for healthcare professionals to help them recognise symptoms, diagnose and treat Eosinophilic Gastrointestinal Diseases.
We work with patients and their carers, medical bodies, manufacturers and funders to ensure the patient’s voice is heard for decisions about treatment guidelines, the development and availability of medicines.

CONFRONTING EOSINOPHILIC DISEASES TOGETHER

Join Us Today

Registered with Fundraising Regulator badge

EOS Network is a British based charity that networks globally

Registered Charity 1143267

Please select a donation amount (required)

£20

Help fund our website and ensure the latest information and support is available.

£30

Urgent research is needed, help fund the projects to find a cure and improve treatments.

£50

We are 100% voluntary run, every penny helps us to improve the lives of those with Eosinophilic Diseases.

£100

Kick start new projects help us reach out, educate and improve Eosinophilic patient care for all.

Other

Set up a regular payment Donate

Latest

EUREOS & TIGERS 2nd Joint Webinar

Following November's success, EUREOS and TIGERS are hosting another interactive webinar on March 3rd. Talks include dietary treatments in EoE and monitoring treatment response.
Eosinophils and COVID Virtual Seminar

Jan 2021 - The International Eosinophil Society (IES) is holding a virtual seminar on 'Eosinophils and COVID'. Talks will include the involvement of eosinophils in viral infections, Covid-19 and eosinophilic diseases, and vaccine hypersensitivity.
US Grants Priority Review for New EoE Treatment

Jan 2021 - The US FDA has granted priority review for Takeda's new budesonide oral suspension for treatment of eosinophilic oesophagitis (EoE). If successful, TAK-721 will be the first EoE treatment to be approved in the US.
Wellbeing Wednesdays: Introduction to Calm

Join EOS Network every Wednesday in January for a series of interactive sessions on calmness and decompressing the stress. A weekly group session for our community members, starting with 'Introduction to Calm' - four sessions throughout January with guest speaker Robyn Silverton.